News

Accentus Medical innovation recognised at Oxfordshire Business Awards

21 June 2012

Oxford, 21 June 2012 … Accentus Medical has been recognised as a successful innovation company at the 2012 Oxfordshire Business Awards. Based at the Harwell Oxford campus, Accentus is a developer and FDA approved manufacturer focused on improving the clinical performance of medical implants. The company has developed and commercialised the Acusure® range of advanced surface coatings designed to improve the biocompatibility and durability of orthopaedic implants. The company is also pioneering the development of an innovative surface treatment called Agluna®, which harnesses the anti-microbial properties of silver ions to significantly reduce infection rates following implant surgery. Agluna® is currently being commercialised within the global orthopaedic industry. The encouraging progress being made by Accentus led to its nomination by the Oxfordshire Business Awards judging panel as a top three finalist in the 2012 Innovation Award category, sponsored by Oxford Brookes University & Business School.

Philip Agg, Chief Executive of Accentus Medical said: “We are delighted to have been recognised within the Oxfordshire business community as a leading innovation company. The company is very proud of the progress it has made in developing and commercialising its innovative technology portfolio within the global medical device market. We look forward to continuing development of our emerging technologies to drive company growth, and to achieving further business success in the future.”

Download PDF

Contact Us

T: +44 (0)1235 434 320
F: +44 (0)1235 434 329
E: enquiries@accentus-medical.com

Acusure